Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2011

View Archived Issues

MEGF-0444A is safe as monotherapy or combined with bevacizumab/paclitaxel in solid tumors

Interim first-in-human data support immunological efficacy of EMD-640744 in advanced solid tumors

Takeda presents new agents for treatment of diabetes

Phase III data on lipegfilgrastim for reduction of neutropenia in breast cancer

Enrollment complete in phase II CRMD-001 trial in contrast-induced acute kidney injury

Rozrolimupab well tolerated and active in patients with primary immune thrombocytopenia

Phase I/II data on navitoclax in lymphoid malignancies updated

Veliparib/temozolomide combination is safe in metastatic unresectable CRC

Lithostathine-1-alpha as a new biomarker in rheumatoid arthritis

Novel photosensitizing agents prepared at Mallinckrodt

Merck & Co. claims new hydroxycarboxylic acid HCA2 receptor agonists

Novel acetyl-CoA carboxylase inhibitors prepared by Pfizer

Roche team synthesizes novel glycogen synthase activators

Synageva BioPharma and Trimeris enter into merger agreement

Arecor and GSK join forces to develop new vaccine formulations

Resverlogix to begin phase IIb ASSURE trial of RVX-208

Abstral launched in Canada for breakthrough cancer pain

Dosing begins in first-in-human trial of VIA-3196 for dyslipidemia

Pathfast cTnI-II (cardiac troponin I) diagnostic test cleared in U.S.

APR and Labtec regain rights to ondansetron oral dispersible film

Adaptimmune begins phase I/II trial of genetically modified T-cell therapies in metastatic melanoma

FDA clears Inform Dual ISH test to help identify candidates for breast cancer therapy Herceptin

FDA accepts for review Novartis' application to expand Menveo indication to infants and toddlers

Nulojix approved in U.S. for prevention of acute kidney transplant rejection in adults

Sprycel indication expanded in Japan to include first-line treatment of chronic myeloid leukemia

Depakene approved in Japan to suppress onset of migraine attacks

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...